Vera Therapeutics (VERA) Change in Account Payables (2020 - 2026)
Vera Therapeutics (VERA) posted Change in Account Payables of -$8.0 million for Q1 2026, down 319.75% on a QoQ basis from $3.6 million in Q4 2025, and down 598.81% year-over-year from $1.6 million in Q1 2025.
Vera Therapeutics (VERA) Change in Account Payables (2020 - 2026) Analysis & Trends
Vera Therapeutics' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$8.0 million for Q1 2026.
- Quarterly Change in Account Payables fell 598.81% year-over-year to -$8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 7.25% YoY) and the FY2025 annual result came in at $13.9 million, up 502.84% from the prior year.
- Change in Account Payables was -$8.0 million for Q1 2026 at Vera Therapeutics, down from $3.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $8.0 million in Q2 2023 and bottomed at -$8.0 million in Q1 2026.
- A 5-year average of $719058.8 and a median of -$62000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables tumbled 1261.11% — and 2025, when it soared 7830.65%.
- Vera Therapeutics' Change in Account Payables stood at $5.0 million in 2022, then sank by 123.74% to -$1.2 million in 2023, then surged by 359.14% to $3.1 million in 2024, then climbed by 18.35% to $3.6 million in 2025, then sank by 319.75% to -$8.0 million in 2026.
- Business Quant data shows VERA's Change in Account Payables at -$8.0 million in Q1 2026, $3.6 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | -7.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.97 Mn |
| Mar 31, 2026 | -7.97 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 3.06 Mn |
| Dec 31, 2024 | 3.06 Mn |
| Sep 30, 2024 | -62,000.00 |
| Sep 30, 2024 | -62,000.00 |
| Jun 30, 2024 | -545,000.00 |
| Jun 30, 2024 | -545,000.00 |
| Mar 31, 2024 | -5.91 Mn |
| Mar 31, 2024 | -5.91 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Dec 31, 2023 | -1.18 Mn |